1.71
+0.05(+3.01%)
Currency In USD
| Previous Close | 1.66 |
| Open | 1.64 |
| Day High | 1.73 |
| Day Low | 1.56 |
| 52-Week High | 2.55 |
| 52-Week Low | 1.19 |
| Volume | 72,281 |
| Average Volume | 82,320 |
| Market Cap | 13.64M |
| PE | -1.33 |
| EPS | -1.29 |
| Moving Average 50 Days | 1.52 |
| Moving Average 200 Days | 1.71 |
| Change | 0.05 |
If you invested $1000 in BioRestorative Therapies, Inc. (BRTX) 10 years ago, it would be worth $0.07 as of October 09, 2025 at a share price of $1.71. Whereas If you bought $1000 worth of BioRestorative Therapies, Inc. (BRTX) shares 5 years ago, it would be worth $24.15 as of October 09, 2025 at a share price of $1.71.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
BioRestorative CEO Lance Alstodt Interviewed on “The Big Biz Show”
GlobeNewswire Inc.
Oct 07, 2025 1:25 PM GMT
MELVILLE, N.Y., Oct. 07, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, today is pleased to ann
BioRestorative Therapies Announces $1.085 Million Registered Direct Offering Priced Above Market
GlobeNewswire Inc.
Oct 06, 2025 6:28 PM GMT
MELVILLE, N.Y., Oct. 06, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, today announced it has entered into definiti
BioRestorative Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire Inc.
Aug 12, 2025 8:05 PM GMT
MELVILLE, N.Y., Aug. 12, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, today reported financia